BRADY IHNEN: Open Payments
NPI 1215406830 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 105 payments from 25 companies in 2025. Trend: 2023 $239 · 2024 $831 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $228 |
| ANI Pharmaceuticals, Inc. | 21 | $173 |
| Travere Therapeutics, Inc. | 7 | $147 |
| Vifor Pharma, Inc. | 9 | $135 |
| Novartis Pharmaceuticals Corporation | 8 | $129 |
| Fresenius USA Marketing, Inc. | 7 | $114 |
| Mallinckrodt Hospital Products Inc. | 4 | $101 |
| Calliditas Therapeutics US Inc. | 3 | $95 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| SCPHARMACEUTICALS INC. | 4 | $70 |
Products named: JARDIANCE, PURIFIED CORTROPHIN GEL, Veltassa, VELPHORO, Fabhalta, ACTHAR, TARPEYO, JYNARQUE.
Industry payments across NE — which companies pay providers there.
